Loading...

Home
Stock
ASND

ASND News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

AI Strategies

AI Stock Picker
Swing Trading
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ASND News

FDA Approves Zycubo for Pediatric Menkes Disease Treatment

3 days agoNASDAQ.COM

Ascendis Pharma (ASND) Stock Rises 7.5% Amid Takeover Speculation

Jan 22 2026seekingalpha

Ascendis Pharma Updates 2026 Strategic Roadmap, Projects €683 Million Revenue

Jan 09 2026Globenewswire

Ascendis Pharma Reports Positive Phase 2 Results for Pediatric Achondroplasia Treatment

Jan 09 2026NASDAQ.COM

Evaluating Ascendis Pharma's 2025 Valuation Following Significant Gains and DCF Growth Potential

Dec 21 2025Yahoo Finance

Ascendis Pharma Rises on Acquisition Rumors

Dec 12 2025SeekingAlpha

March 2026 Options for Ascendis Pharma (ASND) Now Open for Trading

Dec 12 2025NASDAQ.COM

Eight Stock Selections to Capitalize on a Robust Sector of the Market

Dec 11 2025MarketWatch

ASND Events

Ascendis Pharma Shares Rise 2% to $221.31

A rumor regarding Ascendis Pharma was highlighted in Ben Harrington's M&A-focused Betaville blog, contacts tell The Fly. Shares of Ascendis are up $4.65, or 2%, to $221.31 in morning trading.

ASND Monitor News

Ascendis Pharma Stock Falls After Crossing Below 5-Day SMA

Ascendis Pharma hits 20-day high amid market gains

Ascendis Pharma Reports Positive Phase 2 Results for Pediatric Achondroplasia Treatment

Ascendis Pharma rises amid market strength and positive outlook

Ascendis Pharma A/S rises amid sector rotation despite market decline

Ascendis Pharma rises amid sector rotation despite market decline

Ascendis Pharma A/S Declines Amid Market Weakness

ASND.O Hits 52-Week High Amid Strong Demand

ASND Earnings Analysis

Ascendis Pharma A/S Posts Strong Q3 Growth- Intellectia AI™

Ascendis Pharma AS Reports Third Quarter 2024 Financial Results

People Also Watch